936 related articles for article (PubMed ID: 25699255)
21. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
Kang L; Kou Z; Zhang Y; Gao S
J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
[TBL] [Abstract][Full Text] [Related]
22. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
23. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
Menon S; Shailendra S; Renda A; Longaker M; Quarto N
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
[TBL] [Abstract][Full Text] [Related]
24. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
Ito D; Okano H; Suzuki N
Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
[TBL] [Abstract][Full Text] [Related]
25. New approaches for the generation of induced pluripotent stem cells.
Sidhu KS
Expert Opin Biol Ther; 2011 May; 11(5):569-79. PubMed ID: 21314494
[TBL] [Abstract][Full Text] [Related]
26. [Induced pluripotent stem cell technology and its application in disease research].
Cai CY; Meng FL; Rao L; Liu YY; Zhao XL
Yi Chuan; 2020 Nov; 42(11):1042-1061. PubMed ID: 33229312
[TBL] [Abstract][Full Text] [Related]
27. Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells.
Li J; Song W; Pan G; Zhou J
J Hematol Oncol; 2014 Jul; 7():50. PubMed ID: 25037625
[TBL] [Abstract][Full Text] [Related]
28. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
29. The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.
Palomo AB; Lucas M; Dilley RJ; McLenachan S; Chen FK; Requena J; Sal MF; Lucas A; Alvarez I; Jaraquemada D; Edel MJ
J Clin Med; 2014 Apr; 3(2):373-87. PubMed ID: 26237380
[TBL] [Abstract][Full Text] [Related]
30. Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases.
Chang EA; Jin SW; Nam MH; Kim SD
J Korean Neurosurg Soc; 2019 Sep; 62(5):493-501. PubMed ID: 31392877
[TBL] [Abstract][Full Text] [Related]
31. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
[TBL] [Abstract][Full Text] [Related]
32. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
33. [Application of iPSC technology to cancer treatment].
Oshima N; Aoi T
Gan To Kagaku Ryoho; 2015 Feb; 42(2):139-43. PubMed ID: 25743131
[TBL] [Abstract][Full Text] [Related]
34. Generation of induced pluripotent stem cells from somatic cells.
Sohn YD; Han JW; Yoon YS
Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
[TBL] [Abstract][Full Text] [Related]
35. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.
Ishida T; Nakao S; Ueyama T; Harada Y; Kawamura T
Inflamm Regen; 2020; 40():8. PubMed ID: 32426078
[TBL] [Abstract][Full Text] [Related]
36. Imaging of Induced Pluripotent Stem Cells: From Cellular Reprogramming to Transplantation.
Cai W; Zhang Y; Kamp TJ
Am J Nucl Med Mol Imaging; 2011 Aug; 1(1):18-28. PubMed ID: 21841970
[TBL] [Abstract][Full Text] [Related]
37. Biomaterial aided differentiation and maturation of induced pluripotent stem cells.
Velmurugan BK; Bharathi Priya L; Poornima P; Lee LJ; Baskaran R
J Cell Physiol; 2019 Jun; 234(6):8443-8454. PubMed ID: 30565686
[TBL] [Abstract][Full Text] [Related]
38. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
39. Impact of immune response on the use of iPSCs in disease modeling.
Zhang Z; Huang B; Gao F; Zhang R
Curr Stem Cell Res Ther; 2015; 10(3):236-44. PubMed ID: 25019961
[TBL] [Abstract][Full Text] [Related]
40. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.
Hu S; Zhao MT; Jahanbani F; Shao NY; Lee WH; Chen H; Snyder MP; Wu JC
JCI Insight; 2016 Jun; 1(8):. PubMed ID: 27398408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
